Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Novartis (Japan)
InstitutionResearch output, impact & collaborations
Novartis (Japan) is a research organisation in Tokyo, JP. OpenAlex records 729 works and 41,178 citations for it. 259 researchers list it as their most recent affiliation.
729
Works
41,178
Citations
259
Researchers
16
Avg h-index
How has Novartis (Japan)'s publication output changed over time?
ScholarIQpublication output · 1964–2025
Output grew0% over the shown period — from 1 works in 1964 to 1 in 2025.
1
2
1
1
4
1
1
1964196620002016201820212025
Who are the most-cited researchers behind Novartis (Japan)?
ScholarIQtop researchers by citations
What are the most-cited papers on Novartis (Japan)?
ScholarIQmost cited works
The impact of depression among chronic low back pain patients in Japan
Toshinaga Tsuji, Ko Matsudaira, Hiroki Sato, Jeffrey Vietri
BMC Musculoskeletal Disorders. 2016132 CitationsOPEN ACCESS
N.M.R. STUDIES OF BRIDGED RING SYSTEMS: II. UNUSUAL MAGNETIC DESHIELDING EFFECT ON THE BRIDGE METHYLENES OF NORBORNADIENE AND BENZONORBORNADIENE
Kazuo Tori, Yoshiteru Hata, Ryōnosuke Muneyuki, Yoshihiro Takano, Toshinaga Tsuji, Hiroshi Tanida
S9189650. 196469 Citations
A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis
Yuji Uchio, Hiroyuki Enomoto, Levent Alev, Yuki Kato, Hiroyuki Ishihara, Toshinaga Tsuji, Toshimitsu Ochiai, Shin‐ichi Konno
Journal of Pain Research. 201851 CitationsOPEN ACCESS
Work impairment, osteoarthritis, and health-related quality of life among employees in Japan
Ken Nakata, Toshinaga Tsuji, Jeffrey Vietri, Dena H. Jaffe
Health and Quality of Life Outcomes. 201849 CitationsOPEN ACCESS
Association between presenteeism and health-related quality of life among Japanese adults with chronic lower back pain: a retrospective observational study
Toshinaga Tsuji, Ko Matsudaira, Hiroki Sato, Jeffrey Vietri, Dena H. Jaffe
BMJ Open. 201836 CitationsOPEN ACCESS
How much of the research on Novartis (Japan) is open access?
ScholarIQopen access share
73%OPEN ACCESS
Gold
55%
Green
0%
Hybrid
9%
Bronze
9%
Closed
27%